Juhani Knuuti
MD, professor, Turku PET Centre
jknuuti@utu.fi +358 29 450 2345 +358 50 059 2998 Kiinamyllynkatu 4-8 Turku |
Cardiovascular diseases, imaging
Juhani Knuuti’s research has focused on the physiology and pathophysiology, diagnosis and new therapies of coronary artery disease, heart failure and metabolic diseases. The research is also focused on developing and utilizing novel noninvasive imaging methods (PET, SPECT, echocardiography, MRI and CT) that will help to determine the risk and severity of CHD and heart failure and provide guidance for therapy decisions. The recent focus in cardiac research has been on vulnerable plaques, cardiac remodelling and multimodality and hybrid imaging. In metabolic and diabetes research, the focus has been in the interactions between different organs and heart in the pathogenesis and development of the cardiac diseases.
- Cardiac resynchronization therapy - Part 2 - Issues during and after device (2005)
- Journal of the American College of Cardiology
- EANM/ESC procedural guidelines for myocardial perfusion imaging in nuclear cardiology (2005)
- European Journal of Nuclear Medicine and Molecular Imaging
- Efficacy of bioabsorbable antibiotic containing bone screw in the prevention of biomaterial-related infection due to Staphylococcus aureus (2005)
- BONE
- Efficacy of ciprofloxacin-releasing bioabsorbable osteoconductive bone defect filter for treatment of experimental osteomyelitis due to Staphylococcus aureus (2005)
- Antimicrobial Agents and Chemotherapy
- Evaluation of Hepatic Fatty Acid Handling and Triglyceride Release in the Blood Stream Using C-11-Palmitate during Fasting and Euglicemic Hyperinsulinemia (2005)
- European Journal of Nuclear Medicine and Molecular Imaging
- Free Fatty Acid Biodistribution and Triglyceride Metabolism Using the Fatty Acid Analogue 18F-FTHA during Fasting and Hyperinsulinemia (2005)
- European Journal of Nuclear Medicine and Molecular Imaging
- Imaging of Oxidative Metabolism: Insight into cardiac performance (Marie Curie Lecture) (2005)
- European Journal of Nuclear Medicine and Molecular Imaging
- Increased fat mass compensates for insulin resistance in abdominal obesity and type 2 diabetes - A positron-emitting tomography study (2005)
- Diabetes
- Increased lipoprotein(a) is associated with reduced myocardial vasoreactivity in young healthy men (2005)
- Atherosclerosis
- Insulin improves myocardial blood flow in patients with type 2 diabetes and coronary artery disease (2005)
- Journal of the American College of Cardiology
- Is it time for cardiac innervation imaging? (2005)
- Quarterly Journal of Nuclear Medicine and Molecular Imaging
- Lifetime glycaemic exposure predicts reduced coronary vasoreactivity in Type 1 diabetic subjects (2005)
- Diabetic Medicine
- Motion detection and correction for dynamic O-15-water myocardial perfusion PET studies (2005)
- European Journal of Nuclear Medicine and Molecular Imaging
- Rosiglitazone improves myocardial glucose uptake in ischemic regions in patients with type 2 diabetes. A 16 week randomised, double-blind, placebo-controlled study (2005)
- Journal of the American College of Cardiology
- Rosiglitazone improves myocardial glucose uptake in patients with type 2 diabetes and coronary artery disease. A 16 week randomised, double-blind, placebo-controlled study (2005)
- European Heart Journal
- Rosiglitazone improves myocardial glucose uptake in patients with type 2 diabetes and coronary artery disease - A 16-week randomized, double-blind, placebo-controlled study (2005)
- Diabetes
- Rosiglitazone increases the concentration of large, buoyant but not small dense LDL in patients with type 2 diabetes and coronary artery disease, a 16 week randomised, double-blind, placebo-controlled study (2005)
- Diabetes
- Rosiglitazone increases the concentration of large, buoyant but not small dense LDL in patients with type 2 diabetes and coronary artery disease (2005)
- European Heart Journal
- Single nucleotide polymorphisms in the peroxisome proliferator-activated receptor delta gene are associated with skeletal muscle glucose uptake (2005)
- Diabetes
- The assessment of glucose appearance rate and hepatic glucose uptake by [18F]fluorodeoxyglucose: validation against 6,6-2H-glucose (2005)
- Diabetologia